The levels of pGSN/IP-10, pGSN/CTAK, pGSN/IL-6 and pGSN/M-CSF (but not pGSN/HGF) were elevated in patients that were discharged (Figure 2F), suggesting that pGSN levels in combination with inflammatory cytokines especially pGSN/IL-6, may predict mild and favorable outcomes for hospitalized COVID-19 patients. The gene discussed is CXCL10; the disease is COVID-19.